瑞华制药

Jiangsu Ruihua Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical company based in Changzhou, China, specializing in the research, development, and manufacturing of chemical APIs and finished drug products. Established in 2002, the company has built a diverse portfolio targeting therapeutic areas such as cardiovascular health, gastroenterology, and infectious diseases. Ruihua operates state-of-the-art manufacturing facilities that are fully compliant with national GMP standards, ensuring high-quality production for both domestic and international markets. Their product line includes well-known generic medications like amlodipine besylate and lansoprazole, alongside various chemical intermediates. In addition to its own product development, the company provides contract manufacturing (CMO) services, leveraging its expertise in chemical synthesis. Ruihua is committed to technological innovation and quality management to maintain its competitive position in the global pharmaceutical supply chain.